Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment — United States, July 2022–September 2023
by from Morbidity and Mortality Weekly Report (MMWR) on (#6NZA5)
This report describes reports of xylazine use among adults evaluated for substance use treatment.